Erna Domsgen
Stockholm, AB 14152, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
Journal: Microorganisms
Published: October 29, 2020
Determining Laboratory Reference Values of TREC and KREC in Different Age Groups of Iranian Healthy Individuals.
Journal: Iranian journal of allergy, asthma, and immunology
Published: April 15, 2018
New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms.
Journal: Journal of virological methods
Published: November 16, 2017
An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets.
Journal: Scientific reports
Published: August 12, 2016
Coxsackievirus counters the host innate immune response by blocking type III interferon expression.
Journal: The Journal of general virology
Published: March 04, 2016
Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC.
Journal: Archives of virology
Published: October 22, 2015
Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: September 11, 2015
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.
Journal: Diabetologia
Published: July 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026